Month: March 2022
-
Synthetic Antibodies to be Designed with Organoids
A biotechnology enterprise plans to discover synthetic antibodies with 3-D printed lymph node tissue for future licensing to a pharma company.
-
Dealing With Debt When It Gets Out of Control
Spend wisely and follow these strategies to get out of debt and enjoy a debt-free life.
-
Preclinical Study Shows Immune Drug Prevents Covid-19 Death
Findings from research with older lab mice show an oral drug addressing immune deficiencies protects the mice from death by SARS-CoV-2 infections.
-
Infographic – US Public Split on AI, Gene Edits
U.S. residents are largely divided in their views of advances in artificial intelligence and genomics that they may experience now or in the future.
-
NIH Program Releases 100K Whole Genomes Data
A precision medicine research program at National Institutes of Health is releasing to scientists data for nearly 100,000 whole genome sequences.
-
Trial Assessing Digital Data for Covid-19 Vaccine Responses
A clinical trial is evaluating data gleaned from wearable devices for measuring individual physiological reactions to Covid-19 vaccines.
-
Networked Defibrillator Gains $22M in Early Funds
A company creating a networked community defibrillator device for people suffering cardiac arrest is raising $22 million in its first venture round.
-
Photography Project Today
I had photographic assignment with tight deadlines that took up most of the day, so we’ll not have new story today on Science & Enterprise.
-
Virtual Trial to Test Digital Cancer Stress Therapies
A home-based clinical trial is set to begin testing digital therapies for relieving anxiety and managing other health challenges among cancer patients.
-
Infographic – Corp. Venture Funding Leaps in 2021
In 2021, total investments from corporate venture capital reached $169.3 billion for the year, up from $70.1 billion in 2020.